3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
3
Not yet recruiting
3
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
1
Gastrointestinal
1
Conditions
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Neoplasms
1
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Hodgkin Disease
1
Cachexia
1
Interventions
Cyclophosphamide
955
Radiotherapy
847
Cisplatin
756
Gemcitabine
657
Carboplatin
602
Docetaxel
598
Paclitaxel
585
Bevacizumab
579
Fluorouracil
504
Oxaliplatin
458
Rituximab
453
Surveys and Questionnaires
449
Capecitabine
440
Dexamethasone
428
Doxorubicin
423
Etoposide
410
Irinotecan
389
Cytarabine
376
Filgrastim
369
pembrolizumab
327
Leucovorin
305
Nivolumab
295
fludarabine phosphate
294
Melphalan
288
Magnetic Resonance Spectroscopy
280
Blood Specimen Collection
279
Peripheral Blood Stem Cell Transplantation
278
Methotrexate
276
Lenalidomide
276
Cetuximab
269
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
OTHER
×
Accelerometry
×
Clear all
NCT05188755
2022-12-23
CUPCAKE
University Hospital, Clermont-Ferrand
Phase NA
Completed
44 enrolled
NCT02500004
2018-08-03
BAT-Cachexia
Maastricht University Medical Center
Phase NA
Completed
16 enrolled